 |
| 7:30 a.m. |
 |
Breakfast and Registration |
| |
|
|
| 8:30-8:45 a.m. |
|
Industry in Review--A Look at Major Deals and Emerging Trends
To set the context for the day, we will provide a concise analysis of mergers and acquisitions taking place in the healthcare industry. Using The Deal's data, we'll get a quick overview of top deals and the transactions impacting healthcare M&A. |
| |
|
|
| 8:45-9:45 a.m. |
|
Opening Panel: 12 Month Outlook for Healthcare M&A
In 2007 deals in the healthcare M&A marketplace soared. Siemens $7 billion purchase of Dade Behring, Medtronic's purchase of Kyphon and Carlyle Group's purchase of Manor Care are just a few of the deals that contributed to a trend-setting year in the healthcare sector. What can we expect from deal activity moving forward? Will the current pace of healthcare M&A deals continue throughout 2008?
Moderator:
Steven Elek, III, Partner, Healthcare Transaction Services Leader, PricewaterhouseCoopers
Panelists:
Michael Boublik, Co-Head of M&A-Americas, Morgan Stanley, Investment Banking Division
Russell L. Carson, Co-Founder and General Partner, Welsh Carson, Anderson & Stowe
Kenneth W. Hitchner, Partner, Global Head of Healthcare Investment Banking, Goldman Sachs
Todd Sisitsky, Partner, TPG Capital |
| |
|
|
| 9:45-10:15 a.m. |
|
Keynote Interview featuring Vicky Gregg, President and CEO, BlueCross BlueShield of Tennessee
Interviewed by Scott Stuart, Senior Writer, The Deal LLC
|
| |
|
|
| 10:15-10:45 a.m. |
|
Networking Break
|
| |
|
|
| 10:45-11:30 a.m. |
|
Innovations in Healthcare Deal Finance
Moderator:
Michael J. Kaplan, Managing Director, Corporate Ratings, Health Care Team Leader, Standard & Poor's
Panelists:
Robert DeSutter, Co-Head of Healthcare Equity Investment Banking, Piper Jaffray
Chris Gordon, Principal, Bain Capital
Michael J. Kluger, Managing Director, Altaris Capital Partners, LLC
John Leone, Partner, Paul Capital Healthcare |
| |
|
|
| 11:30-12:15 p.m. |
|
Private Equity and the Healthcare M&A Market: What's on the Radar?
Over the past two years, private equity has significantly increased its dollar volume in healthcare M&A, biotechnology, medical devices and pharmaceuticals. While opportunities abound in the healthcare market, which segments hold the most appeal for PE? How deeply will the credit crunch affect private equity activity in the healthcare sector? What type of deal flow can be expected in the months to come?
Moderator:
Michael J. Kaplan, Managing Director, Corporate Ratings, Health Care Team Leader, Standard & Poor's
Panelists:
Benjamin B. Edmands, Managing Director, CCMP Capital, LLC
Jonathan Korngold, Managing Director, Global Head of Healthcare, General Atlantic, LLC
Todd B. Richter, CFA, Managing Director, Global Healthcare Group, Head of Financial Sponsor Coverage & Transaction Development, Bank of America
Nathaniel M. Zilkha, Principal, Kohlberg Kravis Roberts & Co. |
| |
|
|
| 12:15-1:15 p.m. |
|
Networking Lunch |
| |
|
|
| 1:15-2:00 p.m. |
|
Market Spotlight: Healthcare Technology--Deals on the Rise?
Healthcare technology continues to attract capital, raking in the majority of dollars invested in healthcare M&A. With billion-dollar deals on the decline, is there equal opportunity for strategics and private equity in the healthcare technology segment? Will the number of healthcare technology M&A deals in 2008 match or surpass 2007 activity?
Moderator:
George Hill, Vice President, Investment Banking, Leerink Swann
Panelists:
Charles J. Ditkoff, Managing Director, Co-Head of Global Healthcare Group, Corporate & Investment Banking, Banc of America Securities
Ezra Perlman, Partner, Francisco Partners, L.P.
|
| |
|
|
| 2:00-2:45 p.m. |
|
Corporate Dealmaker's Panel
Leading strategic dealmakers active in healthcare M&A will reveal what they look for in a target and how to close the deal. Find out pivotal steps to deal success in the small-to-medium company market. Hear lessons learned directly from dealmakers responsible for corporate development and how they capitalize on emerging growth opportunities.
Moderator:
Kenneth Klee, Editor, Corporate Dealmaker
Panelists:
Christine Arakelian, Vice President, Business Development, Omnicare
June X. Nguyen, Associate Director, Business Development, Eisai, Inc.
Charles Simmons, Vice President, Corporate Development, Bristol Myers Squibb
|
| |
|
|
| 2:45-3:30 p.m. |
|
Regulatory Landscape
Facing the Healthcare Industry
M&A in the healthcare industry persistently raises issues of antitrust violation and enforcement. With 642 deals taking place in 2007 and possibly even more to come in 2008, how will the Federal Trade Commission and Department of Justice handle competition in the healthcare industry? What should hospitals, health insurance and pharmaceutical companies know about anticompetitive practices, compliance and regulation before proposing a merger? Find out how current FTC and DOJ analysis will impact future healthcare M&A deals. Also benefit from a brief synopsis of how fraud and abuse rules can affect mergers.
Moderator:
Cecile Kohrs Lindell, Senior Writer, The Deal LLC
Panelists:
Chul Pak, Partner, Wilson Sonsini Goodrich & Rosati
Fiona Schaeffer, Partner, Weil, Gotshal & Manges LLP
David P. Wales, Jr., Deputy Director, Bureau of Competition, Federal Trade Commission
Richard J. Zall, Partner, Proskauer Rose LLP |
| |
|
|
| 3:30-4:15 p.m. |
|
Licensing Deals
Moderator:
Patrick Clinton, Editor-in-Chief, Pharmaceutical Executive
Panelist:
Annarie Lyles, Ph.D., SVP and Head of Corporate Development, Genmab, Inc.
Robert Knowles, Senior Director, Worldwide Business Development, Pfizer, Inc.
|
| |
|
|
| 4:15-5:30 p.m. |
|
Networking Cocktail Reception |
| |
|
|
| |
|
|
* The Deal LLC reserves the right to alter the agenda of The Healthcare Dealmaking Symposium and/or substitute speakers without advance notice. This agenda remains the sole property of The Deal LLC, and may not be used to market or promote any other conference. Any such unauthorized distribution represents theft of property for which The Deal LLC will pursue any and all appropriate legal remedies.
|
|
